Allogene MSCs Transplantation in Patients With Chronic Liver Diseases Through Peripheral Vein.

计划入组 60 人 · 首次发布于 2010 年 12 月 8 日

Allogene MSCs Transplantation in Liver for Patients With Chronic Liver Diseases Through Portal Vein by Ultrasound Guiding

计划入组 60 人 · 首次发布于 2010 年 12 月 8 日

Turkish Validity and Reliability of the Haptotherapeutic Well-Being Scale

计划入组 252 人 · 首次发布于 2024 年 6 月 20 日

CD19 (Allogene Therapeutics)

CD70/CD19 CAR T(Allogene Therapeutics)

Allogeneic anti-TNFRSF6 CAR-T (Allogene Therapeutics, Inc)

Allogene Therapeutics

United States

Travere Therapeutic

United States

Tectonic Therapeutic, Inc.

United States

CRISPR Weekly Roundup: Advancements in Gene Editing and Clinical Trials

Allogene Pauses Cema-Cel Trial Enrollment, Prioritizes Other Programs

ALLO-316 Granted RMAT Designation by FDA for Advanced Renal Cell Carcinoma